Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean M Connors

Showing results (51-60 of 277) with videos related to

Pageof 28
Sort By:
American Journal of Hematology|April 1, 2018
Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulabilityHanny Al-Samkari, Jean M Connors
Cancers|August 17, 2018
The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated ThrombosisHanny Al-Samkari, Jean M Connors
Hematology. American Society of Hematology. Education Program|December 7, 2019
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancyHanny Al-Samkari, Jean M Connors
Current Opinion in Hematology|August 3, 2020
Venous thromboembolism in the hormonal milieuNathan T Connell, Jean M Connors
Internal and Emergency Medicine|May 25, 2023
Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receiveMelina Verso, Andres Muñoz, Jean M Connors
Frontiers in Medicine|August 7, 2023
Editorial: Hemostasis in ECMO and VAD, volume IIJun Teruya, Jean M Connors, Barbara Zieger
Journal of Thrombosis and Haemostasis : JTH|February 3, 2024
Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection-response to the letter by Kell et alJean M Connors, Robert A S Ariëns
Cancers|October 21, 2020
Management of Cancer-Associated Thrombosis: An Evolving AreaCorinne Frere, Jean M Connors, Dominique Farge
Critical Pathways in Cardiology|July 29, 2016
Idarucizumab (Praxbind) Formulary ReviewJessica Buchheit, Prabashni Reddy, Jean M Connors
The New England Journal of Medicine|September 19, 2019
Anticoagulation for Subsegmental Pulmonary EmbolismAmanda Fernandes, Jean M Connors, Marc Carrier
Pageof 28

Showing results (51-60 of 277) with videos related to

Sort By:
Pageof 28
American Journal of Hematology|April 1, 2018
Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulabilityHanny Al-Samkari, Jean M Connors
Cancers|August 17, 2018
The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated ThrombosisHanny Al-Samkari, Jean M Connors
Hematology. American Society of Hematology. Education Program|December 7, 2019
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancyHanny Al-Samkari, Jean M Connors
Current Opinion in Hematology|August 3, 2020
Venous thromboembolism in the hormonal milieuNathan T Connell, Jean M Connors
Internal and Emergency Medicine|May 25, 2023
Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receiveMelina Verso, Andres Muñoz, Jean M Connors
Frontiers in Medicine|August 7, 2023
Editorial: Hemostasis in ECMO and VAD, volume IIJun Teruya, Jean M Connors, Barbara Zieger
Journal of Thrombosis and Haemostasis : JTH|February 3, 2024
Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection-response to the letter by Kell et alJean M Connors, Robert A S Ariëns
Cancers|October 21, 2020
Management of Cancer-Associated Thrombosis: An Evolving AreaCorinne Frere, Jean M Connors, Dominique Farge
Critical Pathways in Cardiology|July 29, 2016
Idarucizumab (Praxbind) Formulary ReviewJessica Buchheit, Prabashni Reddy, Jean M Connors
The New England Journal of Medicine|September 19, 2019
Anticoagulation for Subsegmental Pulmonary EmbolismAmanda Fernandes, Jean M Connors, Marc Carrier
Pageof 28